Tumor size combined with staging systems for thymoma recurrence prediction: A 28-year experience.

ABSTRACT:

Background

We evaluated a new thymoma prognosis prediction model by combining current staging systems with tumor size.

Methods

The clinical records of thymoma patients in a single center between January 1993 and December 2021 were collected, and data on tumor size and stage and recurrence-free survival (RFS) was obtained. The prediction model was designed by combining staging with tumor size.

Results

During 28 years, 219 thymoma patients were enrolled. Twenty-seven patients had a median RFS of 8.2 years. Further, 153 patients were categorized into limited stage and 66 patients into advanced stage. The RFS was statistically different between these two groups (P = 0.022). The largest area under the curve (AUC) of receiver operating characteristic (ROC) was the dividing

SUBMITTER: Liu HY 

PROVIDER: S-EPMC10656211 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature